Feedback / Questions
Undisclosed in vivo CAR T-cell therapy - Alaya.bio
CELTIC-19 - Alaya.bio
https://www.businesswire.com/news/home/20231019172987/en/Alaya.bio-Acquires-Key-Assets-From-Ixaka-France-Accelerating-the-Progress-of-Its-Novel-In-Vivo-CAR-T-Immunotherapy-Platform
Oct 20, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next